Advanced Glycation Endproduct Crosslinking in the Cardiovascular System: Potential Therapeutic Target for Cardiovascular Disease

Author： Zieman S.J.   Kass D.A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.5, 2004-01, pp. : 459-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The endothelin system:a novel therapeutic target in cardiovascular disease

By Strachan F.E.   Webb D.J.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 95-112

Informa Healthcare

Access to resources Recommend Favorite

Toll-like Receptors Signaling Pathways as a Potential Therapeutic Target in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 24, Iss. 17, 2018-05 ,pp. : 1887-1898

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 23, Iss. 6, 2017-03 ,pp. : 937-943

Bentham Science Publishers

Access to resources Recommend Favorite

P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. : 851-865

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 95-114

Bentham Science Publishers

Access to resources Recommend Favorite